We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

AACC Middle East to Showcase Latest in Laboratory Medicine and Diagnostic Innovations

By LabMedica International staff writers
Posted on 25 Oct 2022
Print article
Image: AACC and Life Dx are bringing the latest developments in laboratory medicine to the Middle East region (Photo courtesy of AACC)
Image: AACC and Life Dx are bringing the latest developments in laboratory medicine to the Middle East region (Photo courtesy of AACC)

AACC Middle East, a two-day conference held by the American Association for Clinical Chemistry (Washington, DC, USA) in partnership with Life Dx (Abu Dhabi, UAE) will bring the latest in laboratory medicine to the Middle East region and showcase diagnostic innovations. The conference will cover a range of timely topics from infectious disease to big data to prenatal emerging technology as well as core laboratory areas in sample transport, lab management, and quality assurance. Each session will be presented by experts in AACC's scientific leadership to bring the latest in laboratory medicine and build new networks among attendees.

The conference to be held in the Grand Hyatt in Dubai, UAE, from November 5-6 will deliver the latest scientific advances in all disciplines pertinent to the field of laboratory medicine. Leaders in laboratory science and management from countries throughout the region including United Arab Emirates, Kuwait, Oman, Bahrain, Qatar, Saudi Arabia, Jordan, Egypt, Turkey, Lebanon, Cyprus, and the entire African continent have been invited to participate. Attendees will include laboratory directors and managers, government officials, and representatives of the diagnostics industry. AACC Middle East attendees will also have the opportunity to network with their peers and experts from the U.S. and the Middle East to share knowledge on new breakthroughs in laboratory medicine. The conference is designed for physicians, lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), medical technologists, pathologists, immunologists, fellows, residents, in-training individuals, and other healthcare professionals interested in laboratory medicine.

AACC Middle East attendees will be able to discuss state-of-the-art research and technologies in laboratory medicine, and incorporate laboratory management strategies that enhance workflows and support accurate and effective testing to improve treatment decisions and patient outcomes. They will also be able to implement up-to-date laboratory testing methods, technologies, and data-driven approaches in the preanalytical, analytical, and postanalytical phases of sample handling. Additionally, participants will be able to describe applications and considerations of data analytics and machine learning in clinical laboratories, summarize advances in biomarkers and screening for neurological disease, assessment of kidney function, preeclampsia, and newborn screening, and demonstrate the value and role of laboratory medicine in treatment decisions and patient outcomes.

Related Links:
Life Dx

Gold Supplier
HAI Assay Quality Control
Amplichek II
Fecal Occult Blood Test
iFOB Assay
Albumin Urine Test
Micro-Albumin ELISA
D-Dimer Test
Epithod 616 D-Dimer Kit

Print article


Clinical Chem.

view channel
Image: ELISA kit for liver-type fatty acid–binding protein (L-FABP). The level of L-FABP present in urine reflects the level of renal tubular dysfunction (Photo courtesy of Sekisui Medical Co)

Urinary Biomarkers Predict Weaning From Acute Dialysis Therapy

Acute kidney injury is associated with a higher risk of chronic kidney disease (CKD), end-stage renal disease, and long-term adverse cardiovascular effects. Critically ill patients with acute kidney injury... Read more


view channel
Image: Ring-form trophozoites of Plasmodium vivax in a thin blood smear (Photo courtesy of Centers for Disease Control and Prevention)

Immune Regulators Predict Severity of Plasmodium vivax Malaria

Cytokines and chemokines are immune response molecules that display diverse functions, such as inflammation and immune regulation. In Plasmodium vivax infections, the uncontrolled production of these molecules... Read more


view channel
Image: Breast cancer spread uncovered by new molecular microscopy (Photo courtesy of Wellcome Sanger Institute)

New Molecular Microscopy Tool Uncovers Breast Cancer Spread

Breast cancer commonly starts when cells start to grow uncontrollably, often due to mutations in the cells. Overtime the tumor becomes a patchwork of cells, called cancer clones, each with different mutations.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.